Navigation Links
Schwartz leaves Merge board; will launch healthcare technology investment fund

West Allis, Wis. -- Merge Technologies Inc. today announced that Abe Schwartz, former CEO of Cedara Software Corp., has stepped down from the company's board of directors in order to launch a new healthcare technology investment fund. The company does business as Merge Healthcare.

Schwartz will continue providing business development assistance to the company beyond his previously ......

Full article >>>
'"/>

Source:wistechnology.com By WTN News 08/26/05


Page: 1

Related biology technology :

1. Legislature adopts one tech bill, leaves two others twisting
2. Senior Wisconsin stem-cell researcher leaves for Connecticut
3. UW-Madison associate dean, active in stem cells, leaves
4. Merge launches diagnostic mammography workstation in Europe
5. Merge Technologies net loss doubles to $10.1M
6. Merge unveils next-generation imaging-informatics product
7. Merge unveils updated medical imaging software
8. Merge Healthcare suffers $258M loss in `06
9. Merge Healthcare unveils diagnostic mammography tool
10. Merge Healthcare promotes Bowers to president
11. Merge Healthcare hires new VP of finance
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/18/2017)... , Jan. 18, 2017   Boston Biomedical ... compounds designed to target cancer stemness pathways, will feature ... compound, napabucasin, at the 2017 ASCO Gastrointestinal Cancers Symposium, ... . Napabucasin is an orally-administered ... targeting STAT3. i Cancer stem cells (CSCs) possess ...
(Date:1/18/2017)... ... January 18, 2017 , ... Whitehouse Labs has ... Albany Molecular Research, Inc. (AMRI), the scientific staff dedicated to Extractables / Leachables ... for further growth in 2017. Extractable & Leachable evaluations have become increasingly more ...
(Date:1/18/2017)... ... 2017 , ... BidMed, LLC, announced it will hold a 1-day ... equipment from two different leading institutes. This highly specialized laboratory equipment is coming directly ... This 1-day online auction will take place on BidMed’s website http://www.bidmed.com ...
(Date:1/18/2017)... Texas , Jan. 18, 2017  Caris ... and the Lustgarten Foundation, the largest private funder ... a clinical trial evaluating the impact of immunotherapy ... providing clinical trial enrollment services to identify potential ... facilitate communication between treating physicians and study investigators. ...
Breaking Biology Technology:
(Date:1/18/2017)...  In vitro diagnostic (IVD) companies were very active ... and Kalorama Information expects that trend to continue – ... Generally, uncertainty in reimbursement and healthcare reform in ... the acquisitions landscape. Instead of looking to buy technology, ... outside of their home country and also to increase ...
(Date:1/12/2017)... -- Trovagene, Inc. (NASDAQ: TROV ), a developer ... it has signed agreements with seven strategic partners across ... Middle East for commercialization of the Trovera™ ... of international distribution agreements for Trovagene,s CLIA based liquid ... The initial partners will introduce Trovagene,s liquid biopsy tests ...
(Date:1/11/2017)... , Jan. 11, 2017 Intoxalock, a ... with the release of its patent-pending calibration device. With ... reliably perform calibrations, securely upload data logs and process ... the customer. "Fighting drunk driving through the ... the public at large, but also for the customer ...
Breaking Biology News(10 mins):